Research Use Disclaimer

You must be 21 or older. Agree to the following terms before accessing product information and pricing.

Research Use Policy Summary

You are 21 years of age or older
All products sold exclusively for laboratory research purposes
Products are not intended for human consumption, diagnosis, or therapeutic use
Purchasers must be qualified researchers or licensed professionals
These products have not been evaluated or approved by the FDA
All sales are final and subject to our research use terms

For laboratory research use only. Not for human or veterinary consumption, diagnostic use, therapeutic use, or clinical use.

Read full Research Use Disclaimer (opens in new tab) →

Product Usage Notice · This product is intended strictly for research and laboratory use only. It is designated for in vitro testing and experimental purposes. Any use involving human or animal consumption is prohibited by law. All information provided on this website is for educational purposes only. This product must only be handled by licensed, qualified professionals. It is not intended for use as a drug, food, or cosmetic, and must not be misused, mislabeled, or misrepresented as such. Read full Research Use Policy →

Compound Information

Technical specifications

Molecular Profile

What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide fragment of a gastric protein, under investigation for cytoprotective signaling, angiogenesis, and tissue remodeling pathways.

Type: Peptide
CAS Number: 137525-51-0
Molecular Weight: 1419.55 g/mol
Amino Acids: 15 residues
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Formula: C62H98N16O22

PubChem Database

BPC-157 · 2025

BPC-157 Research in Musculoskeletal Matrix-Signaling Models HSS Journal Analysis of published research described BPC-157 effects on growth hormone receptor expression, angiogenic pathways, inflammatory cytokine markers, and biomechanical pathway readouts in musculoskeletal models.

View Study

BPC-157 · 2019

Gastric Pentadecapeptide Body pathway modulation Compound BPC 157 and Its Role in Musculoskeletal Soft Tissue Research Cell and Tissue Research Comprehensive review summarizing BPC-157 preclinical research findings across tendon, ligament, and skeletal muscle models. Cited for scientific context only; findings are from animal and in vitro studies.

View Study

BPC-157 · 2011

The Pathway Effect of Pentadecapeptide BPC 157 on Tendon tissue remodeling Involves Tendon Outgrowth, Cell Survival, and Cell Migration Journal of Applied Physiology BPC 157 significantly changed tendon explant outgrowth, increased cell survival under oxidative stress, and reported changes in in vitro migration of tendon fibroblasts in a concentration-dependent manner.

View Study

BPC-157 · 2003

Gastric Pentadecapeptide BPC 157 Changes tissue remodeling of Transected Rat Achilles Tendon and In Vitro Stimulates Tendocytes Growth Journal of Orthopaedic Research BPC 157 changed tendon tissue remodeling biomechanically (increased load-to-failure and elasticity), functionally, and microscopically — showing altered fibroblast formation and collagen deposition.

View Study

BPC-157 · 2020

BPC 157 modulated NSAID-Cytotoxicity Via studying Intestinal Permeability and Enhancing Cytopathway modulation Current Pharmaceutical Design BPC-157 counteracted NSAID-induced intestinal damage by studying intestinal permeability, tracking prostaglandin pathway systems, and tracking leaky-gut syndrome pathways.

View Study

BPC-157 · 2003

Stable Gastric Pentadecapeptide BPC 157 in Intestinal Barrier Pathway Literature Current Pharmaceutical Design Comprehensive review of BPC 157 published development literature for intestinal barrier pathway research, describing mucosal tissue remodeling and inflammatory pathway effects across model systems.

View Study